Cittadini et al. (39) showed that GH therapy in patients with HF could improve LV volume and ejection fraction, but Isgaard et al. (40) reported that no beneficial effects on cardiac function or structure could be detected in patients with HF receiving GH treatment. Here, GH1 is linked to hydrops fetalis.